 or bleeding. Most patients place a higher value
on avoiding early death than on avoiding late outcomes
that affect quality of life.51
A decision analysis evaluating systemic streptokinase in
the treatment of DVT suggests that patients would be
unlikely to accept more than a 1.7-fold increase in major
bleeding compared with heparin therapy.51 On the basis of
individual variation in values and preferences, strategies of
early thrombus removal should be considered a